Category: News

AMT-130, uniQure’s investigational treatment for Huntington’s Disease, reaches an important regulatory milestone

Regulatory applications have been submitted in the United States of America and the United Kingdom

New Confirmatory “PRECISE-HD” study of Pridopidine in HD ready to start recruitment in June

Date of release: 07/07/2026 Dear HD Community, We would like to share an update on the confirmatory PRECISE-HD study (Pridopidine Phase 3 Study to Establish Clinical Impact and Safety in […]

Roche/Genentech Discontinuing Trials

Today Roche shared difficult news. After careful review of the data, they have decided to stop two of their Huntington’s disease studies: GENERATION HD2 and POINT-HD. We’ve provided an overview […]

uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease

3-year analysis from the Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~ Company intends to submit the BLA […]

Skyhawk Therapeutics Announces Twelve-Month Interim Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington’s Disease

Twelve-month findings showed improvement in Composite Unified Huntington’s Disease Rating Scale (cUHDRS) scores from baseline of +0.38, compared to an expected decline of -0.92 points in propensity score-weighted natural history […]

The Arabic Huntington Association is on!

We’re happy to share that the website of the Arabic Huntington Association is now live.This is another important step towards building a stronger and more connected HD community across the […]

The Shape of What’s Happening

When a blind person uses a cane, something strange happens in their brain. The neural map of their body (the internal model that tracks where they end and the world […]

May Awareness 2026: More than HD – Be Part of It.

A global awareness and engagement campaign for Huntington’s Disease launches this May The European Huntington Association (EHA) and the International Huntington Association (IHA) are joining forces again, launching a joint […]

Novartis shares encouraging news on a treatment for Huntington’s Disease

We have received an interesting update from the pharmaceutical company Novartis about the medicine they currently are testing for Huntington’s Disease.   Do you remember the study named PIVOT-HD done a […]

The founding of The Arabic Huntington Association is a sign of a more connected HD community

We are so delighted to share that on 27 March 2026, a significant step forward was taken for the Huntington’s Disease (HD) community in the Arab region. Representatives from several […]